Across TCGA pan-cancer cohorts, NF1P6 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated NF1P6 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher NF1P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NF1P6 expression acts as an unfavorable survival marker, although some lineages such as UCS and LGG show a favorable association.
KICH, BRCA, and DLBC are the cancer types where NF1P6 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.